{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T09:06:06Z","timestamp":1788599166518,"version":"build-2803163510"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T00:00:00Z","timestamp":1611273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T00:00:00Z","timestamp":1611273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Impot Res"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1038\/s41443-020-00400-9","type":"journal-article","created":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T11:29:32Z","timestamp":1611314972000},"page":"164-171","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Combination therapy with topical alprostadil and phosphodiesterase-5 inhibitors after failure of oral therapy in patients with erectile dysfunction: a prospective, two-arm, open-label, non-randomized study"],"prefix":"10.1038","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2734-9387","authenticated-orcid":false,"given":"Pablo","family":"Garrido-Abad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Senra-Bravo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9706-8516","authenticated-orcid":false,"given":"Celeste","family":"Manfredi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2602-2617","authenticated-orcid":false,"given":"Esa\u00fa","family":"Fern\u00e1ndez-Pascual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estefan\u00eda","family":"Linares-Espin\u00f3s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Fern\u00e1ndez-Arjona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Varillas-Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Ignacio","family":"Mart\u00ednez-Salamanca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,22]]},"reference":[{"key":"400_CR1","unstructured":"Salonia A, Bettocchi C, Carvalho J, Corona G, Jones TH, Kadioglu A, et al. Members of the EAU guidelines on sexual and reproductive health panel. Presented at the EAU Annual Congress Amsterdam 2020. 978-94-92671-07-3. Arnhem, The Netherlands: EAU Guidelines Office."},{"key":"400_CR2","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1177\/1756287216644116","volume":"8","author":"B Cuzin","year":"2016","unstructured":"Cuzin B. Alprostadil cream in the treatment of erectile dysfunction: clinical evidence and experience. Ther Adv Urol. 2016;8:249\u201356.","journal-title":"Ther Adv Urol"},{"key":"400_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/smrj.2","volume":"1","author":"I Eardley","year":"2013","unstructured":"Eardley I. The incidence, prevalence, and natural history of erectile dysfunction. Sex Med Rev. 2013;1:3\u201316.","journal-title":"Sex Med Rev"},{"key":"400_CR4","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/S0022-5347(17)34871-1","volume":"151","author":"HA Feldman","year":"1994","unstructured":"Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994;151:54\u201361.","journal-title":"J Urol"},{"key":"400_CR5","doi-asserted-by":"publisher","first-page":"S144","DOI":"10.1038\/sj.ijir.3900594","volume":"12","author":"G Wagner","year":"2000","unstructured":"Wagner G, Fugl-Meyer KS, Fugl-Meyer AR. Impact of erectile dysfunction on quality of life: patient and partner perspectives. Int J Impot Res. 2000;12:S144\u2013S6.","journal-title":"Int J Impot Res"},{"key":"400_CR6","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1097\/01.ju.0000049203.33463.9e","volume":"169","author":"DM Latini","year":"2003","unstructured":"Latini DM, Penson DF, Lubeck DP, Wallace KL, Henning JM, Lue TF. Longitudinal differences in disease specific quality of life in men with erectile dysfunction: results from the Exploratory Comprehensive Evaluation of Erectile Dysfunction study. J Urol. 2003;169:1437\u201342.","journal-title":"J Urol"},{"key":"400_CR7","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1056\/NEJM200006153422407","volume":"342","author":"TF Lue","year":"2000","unstructured":"Lue TF. Erectile dysfunction. N Engl J Med. 2000;342:1802\u201313.","journal-title":"N Engl J Med"},{"key":"400_CR8","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.sxmr.2018.11.007","volume":"7","author":"NE Munk","year":"2019","unstructured":"Munk NE, Knudsen JS, Comerma-Steffensen S, Simonsen U. Systematic review of oral combination therapy for erectile dysfunction when phosphodiesterase type 5 inhibitor monotherapy fails. Sex Med Rev. 2019;7:430\u201341.","journal-title":"Sex Med Rev"},{"key":"400_CR9","doi-asserted-by":"publisher","first-page":"84","DOI":"10.5301\/uro.5000116","volume":"82","author":"I Moncada","year":"2015","unstructured":"Moncada I, Cuzin B. Clinical efficacy and safety of Vitaros\u00a9\/Virirec\u00a9 (Alprostadil cream) for the treatment of erectile dysfunction. Urologia. 2015;82:84\u201392.","journal-title":"Urologia."},{"key":"400_CR10","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1006\/mcbr.2000.0249","volume":"4","author":"NN Kim","year":"2000","unstructured":"Kim NN, Huang Y, Moreland RB, Kwak SS, Goldstein I, Traish A. Cross-regulation of intracellular cGMP and cAMP in cultured human corpus cavernosum smooth muscle cells. Mol Cell Biol Res Commun. 2000;4:10\u20134.","journal-title":"Mol Cell Biol Res Commun"},{"key":"400_CR11","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41443-018-0046-2","volume":"30","author":"I Moncada","year":"2018","unstructured":"Moncada I, Martinez-Salamanca J, Ruiz-Casta\u00f1e E, Romero J. Combination therapy for erectile dysfunction involving a PDE5 inhibitor and alprostadil. Int J Impot Res. 2018;30:203\u20138.","journal-title":"Int J Impot Res"},{"key":"400_CR12","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/sj.ijir.3900472","volume":"11","author":"RC Rosen","year":"1999","unstructured":"Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Pe\u00f1a BM. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res. 1999;11:319\u201326.","journal-title":"Int J Impot Res"},{"key":"400_CR13","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1111\/j.1743-6109.2007.00546.x","volume":"4","author":"A Aversa","year":"2007","unstructured":"Aversa A, Sarteschi LM. The role of penile color-duplex ultrasound for the evaluation of erectile dysfunction. J Sex Med. 2007;4:1437\u201347.","journal-title":"J Sex Med"},{"key":"400_CR14","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/sj.ijir.3901477","volume":"19","author":"D Golijanin","year":"2007","unstructured":"Golijanin D, Singer E, Davis R, Bhatt S, Seftel A, Dogra V. Doppler evaluation of erectile dysfunction\u2014part 1. Int J Impot Res. 2007;19:37\u201342.","journal-title":"Int J Impot Res"},{"key":"400_CR15","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1111\/j.1743-6109.2012.02787.x","volume":"9","author":"AA Carvalheira","year":"2012","unstructured":"Carvalheira AA, Pereira NM, Maroco J, Forjaz V. Dropout in the treatment of erectile dysfunction with PDE5: a study on predictors and a qualitative analysis of reasons for discontinuation. J Sex Med. 2012;9:2361\u20139.","journal-title":"J Sex Med"},{"key":"400_CR16","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41443-018-0087-6","volume":"31","author":"T Cai","year":"2019","unstructured":"Cai T, Palumbo F, Liguori G, Mondaini N, Scroppo FI, Di Trapani D, et al. The intra-meatal application of alprostadil cream (Vitaros\u00ae) improves drug efficacy and patient\u2019s satisfaction: results from a randomized, two-administration route, cross-over clinical trial. Int J Impot Res. 2019;31:119\u201325.","journal-title":"Int J Impot Res"},{"key":"400_CR17","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1111\/j.1743-6109.2009.01627.x","volume":"7","author":"I Eardley","year":"2010","unstructured":"Eardley I, Donatucci C, Corbin J, El-Meliegy A, Hatzimouratidis K, McVary K, et al. Pharmacotherapy for erectile dysfunction. J Sex Med. 2010;7:524\u201340.","journal-title":"J Sex Med"},{"key":"400_CR18","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.eururo.2006.07.020","volume":"51","author":"K Hatzimouratidis","year":"2007","unstructured":"Hatzimouratidis K, Hatzichristou D. Phosphodiesterase type 5 inhibitors: the day after. Eur Urol. 2007;51:75\u201388.","journal-title":"Eur Urol"},{"key":"400_CR19","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/j.1743-6109.2006.00383.x","volume":"4","author":"E Cheng","year":"2007","unstructured":"Cheng E. Real-life safety and efficacy of vardenafil in the treatment of erectile dysfunction-results from 30,010 U.S. patients. J Sex Med. 2007;4:432\u20139.","journal-title":"J Sex Med"},{"key":"400_CR20","doi-asserted-by":"publisher","first-page":"3111","DOI":"10.1111\/j.1743-6109.2009.01432.x","volume":"6","author":"WA Fisher","year":"2009","unstructured":"Fisher WA, Eardley I, McCabe M, Sand M. Erectile dysfunction (ED) is a shared sexual concern of couples II: association of female partner characteristics with male partner ED treatment seeking and phosphodiesterase type 5 inhibitor utilization. J Sex Med. 2009;6:3111\u201324.","journal-title":"J Sex Med"},{"key":"400_CR21","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1136\/bmj.332.7541.589","volume":"332","author":"CN McMahon","year":"2006","unstructured":"McMahon CN, Smith CJ, Shabsigh R. Treating erectile dysfunction when PDE5 inhibitors fail. BMJ. 2006;332:589\u201392.","journal-title":"BMJ"},{"key":"400_CR22","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1097\/01.ju.0000096221.67967.ae","volume":"170","author":"HO Atiemo","year":"2003","unstructured":"Atiemo HO, Szostak MJ, Sklar GN. Salvage of sildenafil failures referred from primary care physicians. J Urol. 2003;170:2356\u20138.","journal-title":"J Urol"},{"key":"400_CR23","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1016\/j.urology.2014.02.016","volume":"83","author":"J Romero Otero","year":"2014","unstructured":"Romero Otero J, Garc\u00eda G\u00f3mez B, Medina Polo J, Jim\u00e9nez Alcaide E, Garc\u00eda Cruz E, Sallent Font A, et al. Evaluation of current errors within the administration of phosphodiesterase-5 inhibitors after more than 10 years of use. Urology. 2014;83:1334\u20138.","journal-title":"Urology."},{"key":"400_CR24","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1111\/jsm.12842","volume":"12","author":"MG Park","year":"2015","unstructured":"Park MG, Yeo JK, Cho DY, Kim JW, Kim JW, Oh MM, et al. The efficacy of combination treatment with injectable testosterone undecanoate and daily tadalafil for erectile dysfunction with testosterone deficiency syndrome. J Sex Med. 2015;12:966\u201374.","journal-title":"J Sex Med"},{"key":"400_CR25","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1517\/14656566.2015.1011124","volume":"16","author":"A Aversa","year":"2015","unstructured":"Aversa A, Francomano D, Lenzi A. Does testosterone supplementation increase PDE5-inhibitor responses in difficult-to-treat erectile dysfunction patients? Expert Opin Pharmacother. 2015;16:625\u20138.","journal-title":"Expert Opin Pharmacother"},{"key":"400_CR26","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.urology.2004.09.013","volume":"65","author":"R Raina","year":"2005","unstructured":"Raina R, Agarwal A, Allamaneni SS, Lakin MM, Zippe CD. Sildenafil citrate and vacuum constriction device combination enhances sexual satisfaction in erectile dysfunction after radical prostatectomy. Urology. 2005;65:360\u20134.","journal-title":"Urology."},{"key":"400_CR27","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1097\/01.ju.0000098460.02560.fe","volume":"171","author":"J Chen","year":"2004","unstructured":"Chen J, Sofer M, Kaver I, Matzkin H, Greenstein A. Concomitant use of sildenafil and a vacuum entrapment device for the treatment of erectile dysfunction. J Urol. 2004;171:292\u20135.","journal-title":"J Urol"},{"key":"400_CR28","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1111\/j.1743-6109.2009.01364.x","volume":"6","author":"O Canguven","year":"2009","unstructured":"Canguven O, Bailen J, Fredriksson W, Bock D, Burnett AL. Combination of vacuum erection device and PDE5 inhibitors as salvage therapy in PDE5 inhibitor nonresponders with erectile dysfunction. J Sex Med. 2009;6:2561\u20137.","journal-title":"J Sex Med"},{"key":"400_CR29","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1016\/j.jsxm.2019.06.009","volume":"16","author":"M El Taieb","year":"2019","unstructured":"El Taieb M, Hegazy E, Ibrahim A. Daily oral l-arginine plus tadalafil in diabetic patients with erectile dysfunction: a double-blinded, randomized, controlled clinical trial. J Sex Med. 2019;16:1390\u20137.","journal-title":"J Sex Med"},{"key":"400_CR30","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1185\/030079904X2394","volume":"20","author":"V Gentile","year":"2004","unstructured":"Gentile V, Vicini P, Prigiotti G, Koverech A, Di, Silverio F. Preliminary observations on the use of propionyl-L-carnitine in combination with sildenafil in patients with erectile dysfunction and diabetes. Curr Med Res Opin. 2004;20:1377\u201384.","journal-title":"Curr Med Res Opin"},{"key":"400_CR31","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.urology.2005.05.014","volume":"66","author":"G Cavallini","year":"2005","unstructured":"Cavallini G, Modenini F, Vitali G, Koverech A. Acetyl-L-carnitine plus propionyl-L-carnitine improve efficacy of sildenafil in treatment of erectile dysfunction after bilateral nerve-sparing radical retropubic prostatectomy. Urology. 2005;66:1080\u20135.","journal-title":"Urology."},{"key":"400_CR32","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1016\/S0022-5347(05)68085-8","volume":"162","author":"CG McMahon","year":"1999","unstructured":"McMahon CG, Samali R, Johnson H. Treatment of intracorporeal injection nonresponse with sildenafil alone or in combination with triple agent intracorporeal injection therapy. J Urol. 1999;162:1992\u20138.","journal-title":"J Urol"},{"key":"400_CR33","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/sj.ijir.3901448","volume":"18","author":"K Nandipati","year":"2006","unstructured":"Nandipati K, Raina R, Agarwal A, Zippe CD. Early combination therapy: intracavernosal injections and sildenafil following radical prostatectomy increases sexual activity and the return of natural erections. Int J Impot Res. 2006;18:446\u201351.","journal-title":"Int J Impot Res"},{"key":"400_CR34","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1159\/000020248","volume":"38","author":"JH Mydlo","year":"2000","unstructured":"Mydlo JH, Volpe MA, Macchia RJ. Initial results utilizing combination therapy for patients with a suboptimal response to either alprostadil or sildenafil monotherapy. Eur Urol. 2000;38:30\u20134.","journal-title":"Eur Urol"},{"key":"400_CR35","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1038\/sj.ijir.3900795","volume":"14","author":"A Nehra","year":"2002","unstructured":"Nehra A, Blute ML, Barrett DM, Moreland RB. Rationale for combination therapy of intraurethral prostaglandin E(1) and sildenafil in the salvage of erectile dysfunction patients desiring noninvasive therapy. Int J Impot Res. 2002;14:S38\u201342.","journal-title":"Int J Impot Res"},{"key":"400_CR36","doi-asserted-by":"publisher","first-page":"757","DOI":"10.2164\/jandrol.05035","volume":"26","author":"R Raina","year":"2005","unstructured":"Raina R, Nandipati KC, Agarwal A, Mansour D, Kaelber DC, Zippe CD. Combination therapy: medicated urethral system for erection enhances sexual satisfaction in sildenafil citrate failure following nerve-sparing radical prostatectomy. J Androl. 2005;26:757\u201360.","journal-title":"J Androl"},{"key":"400_CR37","first-page":"224","volume":"29","author":"H John","year":"1996","unstructured":"John H, Lehmann K, Hauri D. Intraurethral prostaglandin improves quality of vacuum erection therapy. Eur Urol. 1996;29:224\u20136.","journal-title":"Eur Urol"},{"key":"400_CR38","doi-asserted-by":"publisher","first-page":"204","DOI":"10.4081\/aiua.2015.3.204","volume":"87","author":"L Labairu-Huerta","year":"2015","unstructured":"Labairu-Huerta L, Padilla-Fern\u00e1ndez B, Arrondo-Arrondo JL, Valverde-Mart\u00ednez LS, Mart\u00edn-Rodr\u00edguez A, Silva-Abu\u00edn JM, et al. PDE-5 inhibitors in monotherapy versus combination therapy in a sample of 1200 patients with erectile dysfunction. Arch Ital Urol Androl. 2015;87:204\u20139.","journal-title":"Arch Ital Urol Androl"},{"key":"400_CR39","doi-asserted-by":"publisher","first-page":"146","DOI":"10.4081\/aiua.2017.2.146","volume":"89","author":"F Mantovani","year":"2017","unstructured":"Mantovani F. Alprostadil plus Vacuum (VITARUM) in severe erectile dysfunction (ED). Arch Ital Urol Androl. 2017;89:146\u20137. 30","journal-title":"Arch Ital Urol Androl"},{"key":"400_CR40","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1124\/pr.111.004515","volume":"63","author":"KE Andersson","year":"2011","unstructured":"Andersson KE. Mechanisms of penile erection and basis for pharmacological treatment of erectile dysfunction. Pharm Rev. 2011;63:811\u201359.","journal-title":"Pharm Rev"},{"key":"400_CR41","first-page":"123","volume":"8","author":"J Anaissie","year":"2016","unstructured":"Anaissie J, Hellstrom WJ. Clinical use of alprostadil topical cream in patients with erectile dysfunction: a review. Res Rep Urol. 2016;8:123\u201331.","journal-title":"Res Rep Urol"},{"key":"400_CR42","doi-asserted-by":"publisher","first-page":"e13480","DOI":"10.1111\/and.13480","volume":"52","author":"D Arcaniolo","year":"2020","unstructured":"Arcaniolo D, Bellastella G, Manfredi C, Terribile M, Giordano DR, Quattrone C, et al. Is topical alprostadil an usable and reliable alternative to intracavernous injection for penile dynamic duplex ultrasonography? Andrologia. 2020;52:e13480.","journal-title":"Andrologia."},{"key":"400_CR43","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1517\/14656566.5.3.623","volume":"5","author":"E Becher","year":"2004","unstructured":"Becher E. Topical alprostadil cream for the treatment of erectile dysfunction. Expert Opin Pharmacother. 2004;5:623\u201332.","journal-title":"Expert Opin Pharmacother"},{"key":"400_CR44","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S0090-4295(00)00936-5","volume":"57","author":"I Goldstein","year":"2001","unstructured":"Goldstein I, Payton TR, Schechter PJ. A double-blind, placebo-controlled, efficacy and safety study of topical gel formulation of 1% alprostadil (Topiglan) for the in-office treatment of erectile dysfunction. Urology. 2001;57:301\u20135.","journal-title":"Urology."},{"key":"400_CR45","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/sj.ijir.3900940","volume":"15","author":"H Padma-Nathan","year":"2003","unstructured":"Padma-Nathan H, Steidle C, Salem S, Tayse N, Yeager J, Harning R. The efficacy and safety of a topical alprostadil cream, Alprox-TD, for the treatment of erectile dysfunction: two phase 2 studies in mild-to-moderate and severe ED. Int J Impot Res. 2003;15:10\u20137.","journal-title":"Int J Impot Res"},{"key":"400_CR46","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.urology.2006.02.027","volume":"68","author":"H Padma-Nathan","year":"2006","unstructured":"Padma-Nathan H, Yeager JL. An integrated analysis of alprostadil topical cream for the treatment of erectile dysfunction in 1732 patients. Urology. 2006;68:386\u201391.","journal-title":"Urology."},{"key":"400_CR47","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1111\/j.1743-6109.2008.01118.x","volume":"6","author":"M Rooney","year":"2009","unstructured":"Rooney M, Pfister W, Mahoney M, Nelson M, Yeager J, Steidle C. Long-term, multicenter study of the safety and efficacy of topical alprostadil cream in male patients with erectile dysfunction. J Sex Med. 2009;6:520\u201334.","journal-title":"J Sex Med"},{"key":"400_CR48","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1056\/NEJMcp067261","volume":"357","author":"KT McVary","year":"2007","unstructured":"McVary KT. Clinical practice. Erectile Dysfunction. N Engl J Med. 2007;357:2472\u201381.","journal-title":"N Engl J Med"}],"container-title":["International Journal of Impotence Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41443-020-00400-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41443-020-00400-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41443-020-00400-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T12:12:12Z","timestamp":1674907932000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41443-020-00400-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,22]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["400"],"URL":"https:\/\/doi.org\/10.1038\/s41443-020-00400-9","relation":{},"ISSN":["0955-9930","1476-5489"],"issn-type":[{"value":"0955-9930","type":"print"},{"value":"1476-5489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,22]]},"assertion":[{"value":"5 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}